These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 26811922)

  • 1. Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor Biology.
    Thomas DM; Wilhelm M; Cleton-Jansen AM; Dirksen U; Entz-Werlé N; Gelderblom H; Hassan B; Jürgens H; Koster J; Kovar H; Lankester AC; Lewis IJ; Myklebost O; Nathrath MH; Picci P; Whelan JS; Hogendoorn PC; Bielack SS
    J Adolesc Young Adult Oncol; 2011 Sep; 1(3):118-23. PubMed ID: 26811922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report.
    Kager L; Whelan J; Dirksen U; Hassan B; Anninga J; Bennister L; Bovée JVMG; Brennan B; Broto JM; Brugières L; Cleton-Jansen AM; Copland C; Dutour A; Fagioli F; Ferrari S; Fiocco M; Fleuren E; Gaspar N; Gelderblom H; Gerrand C; Gerß J; Gonzato O; van der Graaf W; Hecker-Nolting S; Herrero-Martín D; Klco-Brosius S; Kovar H; Ladenstein R; Lancia C; LeDeley MC; McCabe MG; Metzler M; Myklebost O; Nathrath M; Picci P; Potratz J; Redini F; Richter GHS; Reinke D; Rutkowski P; Scotlandi K; Strauss S; Thomas D; Tirado OM; Tirode F; Vassal G; Bielack SS
    Clin Sarcoma Res; 2016; 6():3. PubMed ID: 27315524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Histopathological diagnostic concordance in bone and soft tissue sarcomas between two comprehensive cancer centers from eastern and western Europe: a collaborative experience].
    Somcutian O; Buiga R; Galatir M; Tudor Eniu D; Rachieru C; Coza D; Terrier P
    Ann Pathol; 2015 Jan; 35(1):32-40. PubMed ID: 25541117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.
    Hingorani P; Janeway K; Crompton BD; Kadoch C; Mackall CL; Khan J; Shern JF; Schiffman J; Mirabello L; Savage SA; Ladanyi M; Meltzer P; Bult CJ; Adamson PC; Lupo PJ; Mody R; DuBois SG; Parsons DW; Khanna C; Lau C; Hawkins DS; Randall RL; Smith M; Sorensen PH; Plon SE; Skapek SX; Lessnick S; Gorlick R; Reed DR
    Cancer Genet; 2016 May; 209(5):182-94. PubMed ID: 27132463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment.
    van Maldegem AM; Bhosale A; Gelderblom HJ; Hogendoorn PC; Hassan AB
    Clin Sarcoma Res; 2012 Jan; 2(1):5. PubMed ID: 22587841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current clinical trials for advanced osteosarcoma and soft tissue sarcoma.
    Sleijfer S; Gelderblom H
    Curr Opin Oncol; 2014 Jul; 26(4):434-9. PubMed ID: 24825018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
    Walter F; Federman N; Apichairuk W; Nelson S; Phelps ME; Allen-Auerbach M; Walter MA; Czernin J
    Pediatr Hematol Oncol; 2011 Oct; 28(7):579-87. PubMed ID: 21936620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1 clinical trials for sarcomas: the cutting edge.
    Subbiah V; Kurzrock R
    Curr Opin Oncol; 2011 Jul; 23(4):352-60. PubMed ID: 21519259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of BCOR-CCNB3 sarcoma using immunohistochemistry for CCNB3: A clinicopathological report of three pediatric cases.
    Shibayama T; Okamoto T; Nakashima Y; Kato T; Sakurai T; Minamiguchi S; Kataoka TR; Shibuya S; Yoshizawa A; Toguchida J; Haga H
    Pathol Int; 2015 Aug; 65(8):410-4. PubMed ID: 26037154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future.
    Ludwig JA
    Curr Opin Oncol; 2008 Jul; 20(4):412-8. PubMed ID: 18525337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. sCD30 and sCD40L detection in patients with osteosarcoma, chondrosarcoma and Ewing sarcoma.
    Solooki S; Khozaei A; Shamsdin SA; Emami MJ; Khademolhosseini F
    Iran J Immunol; 2013 Dec; 10(4):229-37. PubMed ID: 24375064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.
    Asmane I; Watkin E; Alberti L; Duc A; Marec-Berard P; Ray-Coquard I; Cassier P; Decouvelaere AV; Ranchère D; Kurtz JE; Bergerat JP; Blay JY
    Eur J Cancer; 2012 Nov; 48(16):3027-35. PubMed ID: 22682017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
    Quartuccio N; Fox J; Kuk D; Wexler LH; Baldari S; Cistaro A; Schöder H
    AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
    Gorlick R; Anderson P; Andrulis I; Arndt C; Beardsley GP; Bernstein M; Bridge J; Cheung NK; Dome JS; Ebb D; Gardner T; Gebhardt M; Grier H; Hansen M; Healey J; Helman L; Hock J; Houghton J; Houghton P; Huvos A; Khanna C; Kieran M; Kleinerman E; Ladanyi M; Lau C; Malkin D; Marina N; Meltzer P; Meyers P; Schofield D; Schwartz C; Smith MA; Toretsky J; Tsokos M; Wexler L; Wigginton J; Withrow S; Schoenfeldt M; Anderson B
    Clin Cancer Res; 2003 Nov; 9(15):5442-53. PubMed ID: 14654523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006).
    Longhi A; Ferrari S; Tamburini A; Luksch R; Fagioli F; Bacci G; Ferrari C
    Cancer; 2012 Oct; 118(20):5050-9. PubMed ID: 22415578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Round cell sarcomas - biologically important refinements in subclassification.
    Mariño-Enríquez A; Fletcher CD
    Int J Biochem Cell Biol; 2014 Aug; 53():493-504. PubMed ID: 24801613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ewing sarcoma].
    Hamanoue S; Makimoto A
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):175-80. PubMed ID: 17301523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.